Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective Study
Antonio Coppola(University of Cagliari), Annarita Tagliaferri(University of Parma), Paola Ranalli(Ospedale di Santo Spirito), Anna Benegiamo(University of Parma), Gianna Franca Rivolta(University of Parma), Valeria Coluccio(University of Modena and Reggio Emilia), Gabriele Quintavalle(University of Parma), Rossana Rossi(University of Parma), Annalisa Matichecchia(University of Parma), Federica Riccardi(University of Parma)
Cited by 6
Related Papers
Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue
|Blood|2011|205
Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients
|Immunology Letters|2014|101
Caloric Restriction Promotes Immunometabolic Reprogramming Leading to Protection from Tuberculosis
|Cell Metabolism|2021|78
Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months
|Clinical and Translational Allergy|2017|73